Real-World Clinical Outcomes for Patients with <i>EGFR</i> and <i>HER2</i> Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer.

Li, Kelly; Bosdet, Ian; Yip, Stephen; Ho, Cheryl; Laskin, Janessa; Melosky, Barbara; Wang, Ying; Sun, Sophie

Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer.

Li, Kelly; Bosdet, Ian; Yip, Stephen; Ho, Cheryl; Laskin, Janessa; Melosky, Barbara; Wang, Ying; Sun, Sophie.

Affiliation

Li K; Department of Medical Oncology, BC Cancer Agency Vancouver, Vancouver, BC V5Z4E6, Canada.
Bosdet I; Cancer Genetics Laboratory, BC Cancer Agency Vancouver, Vancouver, BC V5Z4E6, Canada.
Yip S; Cancer Genetics Laboratory, BC Cancer Agency Vancouver, Vancouver, BC V5Z4E6, Canada.
Ho C; Department of Medical Oncology, BC Cancer Agency Vancouver, Vancouver, BC V5Z4E6, Canada.
Laskin J; Department of Medical Oncology, BC Cancer Agency Vancouver, Vancouver, BC V5Z4E6, Canada.
Melosky B; Department of Medical Oncology, BC Cancer Agency Vancouver, Vancouver, BC V5Z4E6, Canada.
Wang Y; Department of Medical Oncology, BC Cancer Agency Vancouver, Vancouver, BC V5Z4E6, Canada.
Sun S; Department of Medical Oncology, BC Cancer Agency Vancouver, Vancouver, BC V5Z4E6, Canada.

Curr Oncol ; 30(8): 7099-7111, 2023 07 25.

Article de En | MEDLINE | ID: mdl-37622996

Sujet(s)
Mots clés

EGFR; HER2; NSCLC; exon 20 mutations; real-world outcomes; targeted therapy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Tumeurs du poumon Type d'étude: Prognostic_studies Limites: Aged / Humans Pays/Région comme sujet: America do norte Langue: En Journal: Curr Oncol Année: 2023 Type de document: Article Pays d'affiliation: Canada Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google